Dosage and administration method:
1, Gynecological pelvic inflammatory (including endometritis, salpingitis, tubo-ovarian abscess, pelvic peritonitis)
Intravenous infusion, 500 mg each time, the drug should be administrated not less than 45 minutes, twice a day, the dosing interval is 6-8 hours, continuous administration for 14 days.
2, Suppurative appendicitis, gangrenous appendicitis
Intravenous infusion, 500 mg each time, the drug should be not less than 45 minutes, twice a day, the interval between administrations is 6-8 hours, continuous administration for 5-7 days.
Administration is started within 30 minutes before the surgery preparation is completed and ready for laparotomy.
This product is filled in a 100 mL single-dose soda-lime glass infusion bottle, each containing 0.5 g Morpholinazole and 0.9 g sodium chloride.
This product should be stored in a light-resistant, sealed, and a cool place (not more than 20°C).
Please check the packaging carefully before use, it should be intact; the solution inside it should be clear, no visible particles. As long as the solution and container packaging permit, particulate matters and discoloration of drug should be inspected visually before administration.
After removing the outer packaging, visual inspection should be performed for minor leaks. If leakage is found, the sterility of the product has been destroyed and should be prohibited from using.
This product is a ready-to-use isotonic solution and no need for dilution before use.
Preparation before use:
1. Hang the infusion bottle through the hanging hole.
2. Remove protection cap of infusion mouth.
3. Connect with infusion set.
Note when using:
This product can only be administered as a continuous or intermittent infusion through a slow intravenous infusion. Additives should not be added to this product. If the original intravenous infusion system is used, the original solution should be stopped during Morpholinazole infusion